 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Orgenesis, Inc. is a biotechnology company, which engages in the development, manufacturing, and provision of technologies, and services in the cell and gene therapy industry. It operates through the Morgenesis and Therapies segments. The Morgenesis segment refers to the POCare services. The Therapies segment is involved in therapeutic development operations. The company was founded by Sarah Ferber on June 5, 2008 and is headquartered in Germantown, MD.

Current Price	$1.22
Prev Close	$1.18
Open	$1.18
Dividend Yield	0.00%
50-Day Moving Average	$1.17
Beta	1.01
Avg. Volume	38,789.37
PE Ratio	-2.05

52-Week High	$2.70
52-Week Low	$0.9801
Market Capitalization	$34.57M
EPS	-$0.5946
Price to Book	1.22
Revenue Per Employee	$214,712.58
Enterprise Value/EBITDA	-15.01

ORGS Orgenesis Inc

About

Feed

Fundamentals

News